APOC3 polymorphisms and non-alcoholic fatty liver disease: Resolving some doubts and raising others

Journal of Hepatology

Volumn 55, Issue 6, 2011, Pages 1184-1186

  Romero Gómez, Manuel ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN C3; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ABETALIPOPROTEINEMIA; BIOINFORMATICS; EDITORIAL; GENETIC POLYMORPHISM; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LIPID METABOLISM; LIPID STORAGE; LIVER BIOPSY; LIVER FATTY DEGENERATION; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

APOLIPOPROTEIN C-III; FATTY LIVER; FEMALE; HUMANS; LIPASE; MALE; MEMBRANE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 81255205231     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.06.003     Document Type: Editorial

References (17)

1. L. Valenti, V. Nobili, A. Al-Serri, R. Rametta, J.B.S. Leathart, and M.A. Zappa The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with non-alcoholic fatty liver J Hepatol 55 2011 199 204
2. K.F. Petersen, S. Dufour, A. Hariri, C. Nelson-Williams, J.N. Foo, and X.M. Zhang Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease N Engl J Med 362 2010 1082 1089
3. M. Miller, J. Rhyne, H. Chen, V. Beach, R. Ericson, and K. Luthra APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome Arch Med Res 38 2007 444 451
4. R.L. Pollex, M.R. Ban, T.K. Young, P. Bjerregaard, S.S. Anand, and S. Yusuf Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample BMC Med Genet 8 2007 80
5. V.T. Samuel, K.F. Petersen, and G.I. Shulman Lipid-induced insulin resistance: unravelling the mechanism Lancet 375 2010 2267 2277
6. J. Kozlitina, E. Boerwinkle, J.C. Cohen, and H.H. Hobbs Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance Hepatology 53 2011 467 474
7. Petit JM, Guiu B, Masson D, Cercueil JP, Hillon P, Verges B. Lack of association between an apoC3 genetic variant and liver fat content in patients with type 2 diabetes. Hepatology, in press.
8. J.B. Schwimmer, M.A. Celedon, J.E. Lavine, R. Salem, N. Campbell, and N.J. Schork Heritability of nonalcoholic fatty liver disease Gastroenterology 136 2009 1585 1592
9. J.P. Ioannidis, E.E. Ntzani, T.A. Trikalinos, and D.G. Contopoulos-Ioannidis Replication validity of genetic association studies Nat Genet 29 2001 306 309
10. K. Kantartzis, F. Schick, H.U. Häring, and N. Stefan Environmental and genetic determinants of fatty liver in humans Dig Dis 28 2010 169 178
11. M. Romero-Gómez, and M.E. Saenz-Goñi The genetics of non-alcoholic steatohepatitis and insulin resistance J. Prieto, Genetics in liver disease vol. 2 2007 Permanyer Publications 1 14
12. S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, and L.A. Pennacchio Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
13. Sookoian S, Pirola JC. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology, in press.
14. K. Banasik, J.M. Justesen, M. Hornbak, N.T. Krarup, A.P. Gjesing, and C.H. Sandholt Bioinformatics-driven identification and examination of candidate genes for non-alcoholic fatty liver disease PLoS One 6 2011 e16542
15. C.K. Argo, P.G. Northup, A.M. Al-Osaimi, and S.H. Caldwell Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis J Hepatol 51 2009 371 379
16. Z. Younossi, M. Stepanova, N. Rafiq, H. Makhlouf, Z. Younoszai, and R. Agrawal Pathologic criteria for Non-alcoholic steatohepatitis (NASH): Inter-protocol agreement and ability to predict liver-related mortality Hepatology 53 2011 1874 1882
17. E.K. Speliotes, J.L. Butler, C.D. Palmer, and B.F. Voight GIANT Consortium, MIGen Consortium, PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease Hepatology 52 2010 904 912